Model N is the leader in Revenue Management — an emerging enterprise application category that enables companies to align and improve the processes of pricing and quoting, contract development and management, trade settlements and channel incentives, in order to eliminate the revenue leakage and reduce the financial regulatory compliance risk that can cost companies millions per year. Revenue Management has become a core, strategic focus for companies from all industries that deal with competitive pricing, complex contracts, and multiple channels. Model N offers a unique approach, optimized for life sciences and high tech companies, that combines industry specific solutions and best practices expertise to enable our customers to better plan and control the processes that drive the entire revenue life cycle for their business.

The company believes that our focus on industry specific solutions enables Model N to become a strategic partner to the leaders in the markets we serve. Model N actively recruits expertise within the industry and continues to make investments specific to the needs of the industries we serve. As a result, many of the top companies in high tech semiconductor and electronic components, pharmaceuticals, medical technology and biotech are Model N customers, including: Actelion Biopharmaceuticals, Axcan Pharma, Boston Scientific; Bristol-Myers Squibb; CoTherix, Inc.; Cypress Semiconductor; Gilead Sciences; Integrated Device Technology, Inc.; Intersil Corporation; Linear Technology Corporation; MedImmune, Inc.; Medtronic, Inc.; Microchip Technology, Inc.; Micron Technology Inc.; Novo Nordisk, Inc.; Ortho-Clinical Diagnostics, a Johnson & Johnson company; ON Semiconductor, Inc.; and Pfizer, Inc.